Amiodarone-induced thyrotoxicosis: A diagnostic and therapeutic challenge;Amiodaron-induzierte thyreotoxikose: Eine diagnostische und therapeutische herausforderung

Praxis

Volumn 94, Issue 36, 2005, Pages 1397-1401

  Schuetz, Ph ^a   Eriksson, U ^a   Christ Crain, M ^a   Zulewski, H ^a   Muller B ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

AIT; Amiodaron induced; Case report; Thyroidectomy; Thyrotoxicosis

Indexed keywords

EID: 80051671107     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.94.36.1397     Document Type: Article

References (16)

1. Zulewski H, Siggelkow H, Walden C, Becker W, Hufner M. Evaluation of procollagen III peptide as a marker of tissue hyperthyroidism in long-term treated women with TSH suppressive doses of thyroxine. Exp Clin Endocrinol Diabetes 1999;107(3):190-4. (Pubitemid 29240212)
2. Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med 2000;160(12):1741-8.
3. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997;30(3):791-8.
4. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991;91(5):507-11.
5. Rao RH, McCready VR, Spathis GS. Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab 1986;62(3):563-8. (Pubitemid 16138177)
6. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev 2001;22(2):240-54. (Pubitemid 32458161)
7. Bartalena L, Bogazzi F, Martino E. Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge. Clin Endocrinol (Oxf) 2002;56(1):23-4. (Pubitemid 34107317)
8. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994;78(2):423-7. (Pubitemid 24061764)
9. Leger AF, Massin JP, Laurent MF, Vincens M, Auriol M, Helal OB, et al. Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases. Eur J Clin Invest 1984;14(6):449-55. (Pubitemid 15223759)
10. Nademanee K, Piwonka RW, Singh BN, Hershman JM. Amiodarone and thyroid function. Prog Cardiovasc Dis 1989;31(6):427-37. (Pubitemid 19128264)
11. Osman F, Franklyn JA, Sheppard MC, Gammage MD. Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 2002;105(11):1275-7. (Pubitemid 34260414)
12. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 1996;81(8):2930-3. (Pubitemid 26323888)
13. Bogazzi F, Bartalena L, Cosci C, Brogioni S, Dell'Unto E, Grasso L, et al. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 2003;88(5):1999-2002. (Pubitemid 36549867)
14. Chopra IJ, Baber K. Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism. J Clin Endocrinol Metab 2001;86(10):4707-10. (Pubitemid 33020509)
15. Pearce SH. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol (Oxf) 2004;61(5):589-94. (Pubitemid 39540360)
16. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003;348(26):2646-55. (Pubitemid 36741593)